from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2761c/hsdS

LFCtreatmentdescriptionclass of inhibitor

0.112

Amikacinug/mL Amikacintranslation

-0.353

Cap5-10ug/mL Capreomycintranslation

-0.136

Rox10-50 ug/mL Roxithromycintranslation

-0.850

SM2-5 ug/mL Streptomycintranslation

-2.478

Tet5-10 ug/mL Tetracyclinetranslation

0.906

Rif0.2-5ug/mL Rifampicintranscription

0.328

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.898

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.611

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.101

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.321

Clofazimine10-13 ug/mL Clofaziminerespiration

0.737

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.834

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.597

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.388

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.509

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.201

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.096

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.805

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.710

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.028

KCN5-20 ug/mL Potassium cyaniderespiration

0.561

NaN30.2-2 mM Sodium aziderespiration

0.085

Nigericin50 uM Nigericinrespiration

-0.601

TRC10-150 ug/mL Triclosanrespiration

-1.513

TRZ10-25 ug/mL Thioridazinerespiration

-0.910

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.776

menadione6-10 ug/mL Menadionerespiration

-0.293

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.276

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.156

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.613

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.478

NRP_1Non-replicating persistence stage 1dosRassociated

0.512

Amp0.2mg/mL AmpicillincellWall

0.726

Cephalexin20-100 ug/mL CephalexincellWall

-0.169

Cerulenin0.32-5 ug/mL CerulenincellWall

0.475

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.189

EMB10-20 ug/mL EthambutolcellWall

-0.201

Eta12-40 ug/mL EthionamidecellWall

-0.200

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.017

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.619

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.643

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.698

BZA0.12 mg/mL BenzamidearomaticAmides

0.449

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.073

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.450

H2O24 mM hydrogen peroxideDNAdamaging

0.262

Levo10 ug/mL LevofloxacinDNAdamaging

0.139

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.299

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.147

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.115

UVUV-irradiationDNAdamaging

-0.169

ARP41-4 ug/mL Antitubercular compound ARP4?

0.205

Antimycin12.5-50 ug/mL Antimycin A?

0.358

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.831

PA_110-50 ug/mL Antitubercular compound PA-1?

0.565

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.795

PA8240.2-2 ug/mL PA-824?

-0.445

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.213

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.365

Verapamil50 uM Verapamil?

0.806

mercaptoethanol2 mM 2-Mercaptoethanol?

0.987

methoxatin10-20 ug/mL Methoxatin?